Rohit Loomba - Concepedia

Author

Rohit Loomba

University of California San Diego ORCID

Also Known As

Arun J. Sanyal, Atsushi Nakajima, Claude B Sirlin, Daniela Allende, Egbert Madamba, Hong Kai Lim, Kathryn Harlow, Loomba R, Loomba, R., Loomba, Rohit

1.2K

Publications

99K

Citations

152

H-Index

228

Concepts

All Affiliations

University of California San Diego Virginia Commonwealth University Johns Hopkins University Saint Louis University Pinnacle Clinical Research

About

Rohit Loomba is an author at University of California San Diego specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	65	146	25.4K
2	Health Sciences	45	79	11.9K
3	Engineering	3	3	126
4	Language Studies	1	1	397
5	Natural Sciences	1	1	14

Rohit Loomba

404

Publications

55.8K

Citations

114

H-Index

Page 1

	Year	Citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, The Lancet HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled Trial	2014	2.2K
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, Hepatology	2023	2K
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Chris Estes, Quentin M. Anstee, M. Arias, Journal of Hepatology	2018	1.9K
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, New England Journal of Medicine	2024	1.4K
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 Peng Zhang, Lihua Zhu, Jingjing Cai, Circulation Research	2020	1.2K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease Rohit Loomba, Victor Seguritan, Weizhong Li, Cell Metabolism DysbiosisHepatologyMedicineLiver PhysiologyGut Microbiology	2017	1.1K
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, New England Journal of Medicine	2021	986
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease Charlie C. Park, Phirum Nguyen, Carolyn Hernandez, Gastroenterology Metabolic Associated SteatohepatitisHepatologyMedical ImagingNonalcoholic Fatty Liver DiseaseMagnetic Resonance Elastography	2016	684

Page 1